Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Company’s Segments Including a Reconciliation to Income Before Taxes

The tables below provide information about the Company’s segments and include a reconciliation to income before taxes:

Three Months Ended March 31, 2025		Fertility Clinic Services				INVOcell Device				Therapeutics				Total
Revenue from external customers			1,621,553				15,632				-				1,637,185
Intersegment revenues			-				4,500				-				4,500
Total revenue			1,621,553				20,132				-				1,641,685
Reconciliation of revenue
Elimination of intersegment revenue															(4,500	)
Total consolidated revenue															1,637,185
Less:
Cost of revenue			1,060,243				3,984				-				1,064,227
Sales and marketing			12,974				-				-				12,974
General and administrative			307,101				-				1,000,583				1,307,684
Research and development			-				-				265,663				265,663
Impairment loss			-				-				14,645,069				14,645,069
Depreciation and amortization			212,456				2,431				-				214,887
Segment profit (loss)			28,778				13,717				(15,911,315	)			(15,873,319	)
Reconciliation of net loss
Other income (loss)															15,096
Interest expense															(311,270	)
Unallocated amounts:
Other corporate expenses															(1,229,593	)
Loss before taxes															(17,399,086	)

Assets			10,654,643				39,534				16,942,932

Three Months Ended March 31, 2024		Fertility Clinic Services				INVOcell Device				Therapeutics				Total
Revenue from external customers			1,537,199				39,087				-				1,576,286
Intersegment revenues			-				-				-				-
Total revenue			1,537,199				39,087				-				1,576,286
Reconciliation of revenue
Elimination of intersegment revenue															-
Total consolidated revenue															1,576,286
Less:
Cost of revenue			865,104				(2,999	)			-				862,105
Sales and marketing			7,609				-				-				7,609
General and administrative			272,081				-				-				272,081
Research and development			-				-				-				-
Depreciation and amortization			212,382				2,431				-				214,813
Segment profit (loss)			180,024				39,655				-				219,679
Reconciliation of net loss
Other income (loss)															94,655
Interest expense															(181,295	)
Unallocated amounts:
Other corporate expenses															(1,727,716	)
Loss before taxes															(1,594,677	)

Assets			11,471,948				49,259				-